NTRB

Nutriband Inc. operates in the healthcare sector, specifically within the biotechnology industry. Its market capitalization is $54.54 million. The company's financial health is marked by significant losses, with a net income of -$34,592,176 over the trailing twelve months (TTM). This is accompanied by an operating margin of -1121.3% and a profit margin of 0.0%. The gross margin stands at 33.5%, indicating that it generates revenue from sales but struggles to maintain profitability. Nutriband's returns on equity (-136.1%) and assets (-55.2%) are also negative, indicating a lack of earnings generation. Its balance sheet shows $258,025 in debt against $5.31 million in cash. Nutriband Inc.'s valuation metrics include a price-to-book ratio of 7.21 and a price-to-sales ratio of 23.94. The forward P/E ratio is -19.48, indicating that the company's stock price has declined compared to its earnings projections. Revenue growth over the past year (YoY) was -46.4%, while there is no available data on earnings growth. Dividend information is not applicable as the payout ratio is 0.0%.